Organon Pharma Indonesia Tbk. vs Solusi Sinergi Digital Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Solusi Sinergi Digital Tbk. trades at Rp1,995 (market cap 10.88T, 24.13M 24h volume). The key difference: Solusi Sinergi Digital Tbk. is far larger — about 104.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WIFI | |
|---|---|---|
Market Cap | 104.4B | 10.88T |
Volume | — | 24.13M |
Lot | — | 241.31K |
Turnover | — | 48.25B |
Average Price | — | 1,999.27 |
Value | — | 48.25B |
Indicative Equilibrium Price | — | 1,995 |
Indicative Equilibrium Volume | — | 11.93K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Solusi Sinergi Digital Tbk (the Company) was established based on Notarial Deed No. 21 of Humberg Lie, S.H., S.E., M.Kn dated September 6, 2012. The Company begin their operation activities in 2012.
Read more on WIFI →